LivDerm
The Future of Atopic Dermatitis, JAK Inhibitors, and Monoclonal Antibodies: What Are the Differences, Efficacy, and Safety With New Pharmacologics?
By
LivDerm
FEATURING
Lawrence Schachner
By
LivDerm
FEATURING
Lawrence Schachner
Login to view comments.
Click here to Login
2021 Masters of Pediatric Dermatology